Current advances in early detection, residual disease monitoring and treatment response in lung cancer: Liquid biopsy
Journal Title: Current Thoracic Surgery - Year 2018, Vol 3, Issue 2
Abstract
Lung cancer exhibits the highest mortality rate of all malignant tumors, and only a minority of non-small cell lung cancer (NSCLC) patients are diagnosed with localized, early stage tumors. Unfortunately, NSCLC is usually detected at advanced and inoperable stages. Tumor biomarkers can detect early stage lung cancer independently or in combination with low-dose computed tomography-based screening techniques. A liquid biopsy is a noninvasive modality for the pathological and molecular characterization of cancer, and it can be isolated from bodily fluids. There are a variety of biological elements that can be isolated from the peripheral blood, such as exosomes, circulating cell-free (tumor) DNA, circulating tumor cells, and microRNA. A liquid biopsy can be used to detect somatic mutations before treatment and dynamically during treatment, and to monitor the treatment response. It can also be used for minimal residual disease quantification, and to determine the emergence of therapy resistance. Despite the numerous research studies showing successful results, clinically available lung cancer biomarkers do not have sufficiently high specificity and sensitivity for widespread use. Therefore, universal experimental and therapeutic research regarding advanced molecular diagnostics has become necessary.
Authors and Affiliations
Ebru Sayılır Güven, Selim Şakir Erkmen Gülhan
Role of surgical fixation in rib fractures: an experimental study
Background: Rib fractures occur usually after thoracic traumas. Multiple and displaced fractures are occasionally associated with respiratory complications. That is why treatment for rib fractures should be done properly...
Can vasculitis be the cause of acute onset pulmonary venous thrombosis and gangrene after bilobectomy in a patient with bronchiectasis: a case report
Pulmonary venous thrombosis is a rare condition, often seen after lung transplantation, malignancies, fungal infections and sclerosing mediastinitis. It is a life threatening complication which may develop after a thorac...
Multimodality treatment of primary mediastinal germ cell tumor with growing teratoma syndrome: a case report
Germ cell tumors arise from errors occurring during the migration of embryonic stem cells to the gonads. They constitute 10-15% of malignant mediastinal tumors. Thirty-nine years old male patient was admitted with shortn...
Scar revision after minimal invasive repairment of pectus deformities
Pectus excavatum and pectus carinatum are the most common congenital chest wall deformities among others. The current surgical treatment involves insertion of a pectus bar to correct the deformity. It is a minimal invasi...
Surgical results of herpes zoster and lung cancer association in preoperative period
Herpes zoster also known as shingles is a disease caused by the reactivation of varicella zoster virus. It often starts with erythema as the first finding. Maculopapular vesicles may form painful rashes with maturations,...